For a medical practitioner
Late-onset epilepsy: peculiarities of diagnostics and treatmentMaryenko L.B. Maryenko K.M. 1(141) – I/II 2021 7
Treatment of Parkinson’s disease: the potential of extended-release pramipexoleKaraban I.M. 1(141) – I/II 2021 12
Neurometabolic strategy of pharmacotherapy of affective disorders: whom, when and why?Burchinsky S.G. 1(141) – I/II 2021 9
Coronavirus disease 2019 (COVID-19) and pregnancy. Literature reviewSytnik P.O. Sytnik P.O. 6(1) (140) – XI/XII 2020 18
Psychogenic nonepileptic seizures (PNES) — multidisciplinary problemDubenko A.Ye. Naboka M.V. 6(1) (140) – XI/XII 2020 5
Clinical and epidemiological features of the diphtheria outbreak among foreign students of Uzhgorod National UniversityTuryanitsya S.M. Pikina I.Yu. 5(2) (139) – IX/X 2020 5
Anxiety and anxiety states in gynecological practice: possibilities and tools of pharmacotherapyBurchinsky S.G. 4 (138) – VII/VIII 2020 5
Effectiveness of lamotrigine in children and adolescents with conduct disordersMartsenkovsky I.A. Martsenkovska I.I. Skripnik T.O. Makarenko G.V. 4 (138) – VII/VIII 2020 6
Osteoarthritis and comorbidity: features of treatment of patients at the present stageSoroka М.F. 2020-07-29 8
Multiple sclerosis and pregnancy
Natural polyphenols as inhibitors of coronavirus-cell interaction: review of literature and experimental dataDeriabin O.M. Zavelevych M.P. Starosyla D.B. Palchykovska L.G.... 3(1) (137) – V/VI 2020 9
Withdrawal of antiepileptic treatment — benefits, risks, expediency and safetyMaryenko L.B. 2020-05-21 6
Clarithromycin — an antibacterial defense proven by time
Morphological manifestation of gylcogen synthesis in the uterus as one of the target markers of reproductive successMishyna K.M. Kuzyk P.V. Gichka S.G. 2(2) (136) – III/IV 2020 6
Clinical features of the use of lamotrigine in pregnant women with epilepsyHertsev V.N. Goransky Yu.I. 2(1) (136) – III/IV 2020 12
